OncBioMune Pharmaceuticals Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Reverse Merger

  • Financing Rounds
  • 1

  • Investments
  • 1

OncBioMune Pharmaceuticals General Information

Description

Developer of biotechnology products for cancer treatment. The company engages in marketing and distribution of hospital specialty pharmaceutical prescription products.

Contact Information

Formerly Known As
Quint Media
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 17050 Medical Center Drive
  • Baton Rouge, LA 70816
  • United States
+1 (225)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • 17050 Medical Center Drive
  • Baton Rouge, LA 70816
  • United States
+1 (225)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OncBioMune Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore OncBioMune Pharmaceuticals‘s full profile, request access.

Request a free trial

OncBioMune Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of biotechnology products for cancer treatment. The company engages in marketing and distribution of hospital
Drug Discovery
Baton Rouge, LA
5 As of 2025

Basel, Switzerland
 

North Chicago, IL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OncBioMune Pharmaceuticals Competitors (37)

One of OncBioMune Pharmaceuticals’s 37 competitors is Novartis, a Corporation company based in Basel, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Novartis Corporation Basel, Switzerland
AbbVie Corporation North Chicago, IL
Lilly USA Corporation Indianapolis, IN
Liquidia Formerly VC-backed Morrisville, NC
China Resources Pharmaceutical Group Corporation Hong Kong, Hong Kong
You’re viewing 5 of 37 competitors. Get the full list »

OncBioMune Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OncBioMune Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore OncBioMune Pharmaceuticals‘s full profile, request access.

Request a free trial

OncBioMune Pharmaceuticals Acquisitions (1)

OncBioMune Pharmaceuticals’s most recent deal was a Merger/Acquisition with Vitel Laboratorios. The deal was made on 10-Mar-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Vitel Laboratorios 10-Mar-2017 Merger/Acquisition Other Healthcare Services
To view OncBioMune Pharmaceuticals’s complete acquisitions history, request access »

OncBioMune Pharmaceuticals FAQs

  • When was OncBioMune Pharmaceuticals founded?

    OncBioMune Pharmaceuticals was founded in 2005.

  • Where is OncBioMune Pharmaceuticals headquartered?

    OncBioMune Pharmaceuticals is headquartered in Baton Rouge, LA.

  • What is the size of OncBioMune Pharmaceuticals?

    OncBioMune Pharmaceuticals has 5 total employees.

  • What industry is OncBioMune Pharmaceuticals in?

    OncBioMune Pharmaceuticals’s primary industry is Drug Discovery.

  • Is OncBioMune Pharmaceuticals a private or public company?

    OncBioMune Pharmaceuticals is a Private company.

  • What is OncBioMune Pharmaceuticals’s current revenue?

    The current revenue for OncBioMune Pharmaceuticals is .

  • Who are OncBioMune Pharmaceuticals’s investors?

    Quint Media, Inc. has invested in OncBioMune Pharmaceuticals.

  • Who are OncBioMune Pharmaceuticals’s competitors?

    Novartis, AbbVie, Lilly USA, Liquidia, and China Resources Pharmaceutical Group are some of the 37 competitors of OncBioMune Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process